期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清碱性磷酸酶和肌酐测定在前列腺癌骨转移中的鉴别诊断意义 被引量：2

下载PDF
导出
摘要 目的探讨前列腺癌骨扫描超级显像者血清碱性磷酸酶、肌酐水平测定对是否骨转移超级显像的诊断意义方法回顾分析前列腺癌SPECT骨扫描超级显像35例(超级显像组),骨无转移肾不显影31例(肾不显影组),骨无转移肾显影35例(显像正常组),比较超级显像组与肾不显影组、显像正常组血清碱性磷酸酶、肌酐水平。结果超级显像组血清碱性磷酸酶(664.09±325.299)U/L,显著高于肾不显影组(115.81±31.933)U/L(P<0.01)和显像正常组(81.66±15.333)U/L(P<0.01);超级显像组血清肌酐(80.86±18.406)μmol/L正常,可排除肾性骨病。结论血清碱性磷酸酶及肌酐水平有助于判别前列腺癌骨显像是否为骨转移超级显像。
作者 高钱纲 刘威平 钟吉俊
机构地区 台州市中心医院
出处 《浙江实用医学》 2013年第4期263-265,共3页 Zhejiang Practical Medicine
关键词 前列腺癌 超级显像 碱性磷酸酶 肌酐
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献11

二级参考文献50

  • 1范义湘,罗荣城,李贵平,黄凯.骨显像联合血清骨型碱性磷酸酶诊断恶性肿瘤骨转移[J].第一军医大学学报,2004,24(7):812-814. 被引量：7
  • 2ZHU Ruisen, LU Hankui, LUO Quanyong, et al. Nucl Sci Tech, 2005, 118(5): 425-428.
  • 3Coleman RE.Skeletal complications of malignancy.Cancer,1997,80:1588-1594.
  • 4Carlin BI,Andriole GL The natural history,skeletal complications,and management of bone metastases in patients with prostate carcinoma.Cancer,2000,88:2989-2994.
  • 5Adami S.Bisphosphonates in prostate carcinoma.Cancer,1997,80:1674-1679.
  • 6Abuzallouf S,Daves I,Lukka H.Baseline staging of newly diagnosed prostate cancer:a summary of the literature.J Urol,2004,171:2122-2127.
  • 7Smith MR,Eastham J,Cleason DM,et al.Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.J Urol,2003,169:2008-2012.
  • 8Saad F.The role of bisphosphonates in the management of prostate cancer.Curr Oncol Rep,2006,8:221-227.
  • 9Petrylak DP,Tangen CM,Hussain MH.et al.Docetaxel and estranustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.N Engl J Med,2004,351:1513-1520.
  • 10Saad F,Cleason DM,Murray R,et al.Zoledronic acid prostate cancer study group.Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.J Natl Cancer Inst,2004,96:879-882.

共引文献77

同被引文献27

  • 1李红,周昕,付鹏,张红芳.血清碱性磷酸酶动态检测在恶性肿瘤骨转移中的临床价值[J].医学信息（医学与计算机应用）,2014,0(28):43-43. 被引量：2
  • 2Huggins C,Stevens RE,Hodges CV. Studies on prostatic cancer.The effects of castration on adavanced carcinan a of the prostategland[ J]. Arch Surg,1941,43(2) :209 -223.
  • 3Omar Abdel - Rahman. Castration 一 resistant prostate cancer(CRPC) : the rise and fall of systemic chemotherapy. Shadowsof recent phase 3 studies [ J ] . Chinese - German J Clin Oncol,2014,13(3);144-145.
  • 4Feldnan BJ, Feldman D. The development of androgen - independ-ent prostate caner [ J ]. Net Rav Cancer, 2001,1(1):34 -35.
  • 5Zhao H,Han KL,Wang ZY,et al.Value of C-telopeptidecross-linked Type I collagen,osteocalcin,bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors[J].Medical science monitor:international medical journal of experimental and clinical research.2011,17(11):CR626-33.
  • 6Metwalli AR,Rosner IL,Cullen J,et al.Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer[J].Urologic oncology.2014.
  • 7Han KS,Hong SJ.Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis[J].Journal of cancer research and clinical oncology.2014.
  • 8张立,翁绳美.前列腺癌内分泌药物治疗的现状与展望[J].海峡药学,2008,20(6):11-13. 被引量：4
  • 9王福利,符生苗,邓立群,吴艳.前列腺癌血清诊断标志物研究进展[J].海南医学,2010,21(22):12-15. 被引量：7
  • 10郭枫,陈琳,李运柱,彭松,李国灏,朱晨曦,余家俊,王勇,万志华.前列腺特异抗原和碱性磷酸酶联合检测在早期诊断前列腺癌骨转移中的应用[J].武汉大学学报（医学版）,2012,33(3):394-396. 被引量：12

二级引证文献19

浙江实用医学
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部